Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dianthus Therapeutics announced the grant of equity awards to three newly-hired, non-executive employees on November 2, 2026. The inducement grants consist of non-qualified stock options to purchase 26,000 shares of common stock with an exercise price of $82.25 per share and a 10-year term, vesting 25% after one year followed by equal monthly installments over 36 months.